NORTHBROOK, Ill., June 28, 2012 -- Astellas Pharma US, Inc. ("Astellas"), a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), announced today that the U.S. Food and Drug ...

NORTHBROOK, Ill., Oct. 22, 2012 -- Astellas Pharma US, Inc. ("Astellas"), a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), announced today that MYRBETRIQ™ (mirabegron) ...

Myrbetriq approved for overactive bladder Myrbetriq is indicated for adults with overactive to minimize symptoms of frequent urination and urinary incontinence. HealthDay News — The FDA has approved ...

Lupin is launching mirabegron ER tablets, 50 mg, which is a generic of Astellas Pharma’s Myrbetriq. Myrbetriq is used to treat overactive bladder with symptoms of urgency, frequency and leakage in ...

18 Aug 2012, USA, Wshington( Zeepharmacy.com): The Astellas Pharma US, Inc's extended release tablets of Myrbetriq has been approved by the FDA (Food and Drug Administration) for curing symptoms ...

Astellas Pharma Inc. announced that the US Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for the use of mirabegron in combination with the muscarinic ...

Myrbetriq safe, effective alternative tx for OAB High discontinuation rates with traditional second-line therapies suggest more overactive bladder treatment options are needed. Washington, DC — ...

Before you start treatment with Myrbetriq, tell your doctor and pharmacist which prescription, over-the-counter, and other medications you take. By sharing this information with them, you may help ...

Most Medicare drug plans cover the cost of mirabegron (Myrbetriq). But you’ll likely still have out-of-pocket costs. Many of the discount coupons available cannot be used with Medicare. The price may ...

Zydus is introducing mirabegron extended-release tablets, 25 mg, which is the generic of Myrbetriq. Zydus is among the first suppliers to launch the generic version of mirabegron extended-release ...